Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.50
+0.09 (1.40%)
At close: Jun 5, 2026, 4:00 PM EDT
6.21
-0.29 (-4.46%)
After-hours: Jun 5, 2026, 7:21 PM EDT
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $167.71 million as of June 5, 2026. Its market cap has increased by 225.28% in one year.
Market Cap
167.71M
Enterprise Value
95.00M
1-Year Change
225.28%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $167.71M, a decrease of -80.39%. That is a compound annual growth rate of -20.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 167.71M | 67.48% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 176.46M |
| Immunic | 173.95M |
| Cartesian Therapeutics | 171.59M |
| Enlivex | 171.14M |
| OnKure Therapeutics | 168.85M |
| Milestone Pharmaceuticals | 167.34M |
| Innate Pharma | 166.86M |
| Spero Therapeutics | 163.28M |